HN cancers and malignancies of the FGT demonstrated significant anemia, with Hb levels of 11.2 ± 2.9 g/dL and 10.9 ± 2.1 g/dL, respectively (p < 0.001). The gene discussed is GSTM1; the disease is anemia.